FDA hears of problems with Med Guides
July 9th 2007The Food and Drug Administration's "Medication Guide" program, set up nine years ago as a major avenue of informing patients about risks or special issues with certain drugs, has a host of problems, according to pharmacists and other witnesses at a recent hearing.
Drug-resistant TB: Should Americans be worried?
July 9th 2007Most Americans probably never gave tuberculosis (TB) a passing thought until a case of extensively drug-resistant TB (XDR TB) recently made national headlines. An American with XDR TB traveled from the United States to Europe and back in May, potentially exposing hundreds of fellow travelers to the disease. Since then, national public concern about TB has ballooned.
New antihistamine gets FDA green light
July 9th 2007Adults and children six years of age and older who suffer with seasonal and perennial allergic rhinitis will now have another option for relief of their symptoms. Levocetirizine (Xyzal) from UCB Inc. and Sanofi-Aventis has received regulatory approval from the FDA.
New form of progesterone approved
July 2nd 2007A progesterone vaginal insert has been OK'd for marketing and will be sold under the name Endometrin, from Ferring Pharmaceuticals. The new formulation will be available in a100-mg strength and is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an assisted reproductive technology treatment for infertile women.